💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

More on Sabra Health Care Q2: Sees upturn in 2019

Published 08/08/2018, 05:49 PM
© Reuters.  More on Sabra Health Care Q2: Sees upturn in 2019
SBRA
-
  • Sabra Health Care (NASDAQ:SBRA) Q2 adjusted FFO per share of 61 cents misses consensus by 2 cents and compares with 55 cents a year ago.
  • Total revenue more than doubled to $166.3M from $64.7M a year ago.
  • Reaffirms previously issued 2018 guidance.
  • "We expect that occupancy and coverages for our skilled nursing portfolio and the sector as a whole are close to bottom and that we will see an upturn in 2019, with senior housing lagging somewhat behind due to existing oversupply," says Chairman and CEO Rick Matros.
  • Skilled nursing/transitional care occupancy 81.8% vs. 81.6% in Q1.
  • Senior housing-leased occupancy 56.2% vs. 86.5% Q/Q.
  • Specialty hospitals and other occupancy 86.3% vs. 83.4% Q/Q.
  • During Q2, Sabra completed the sale of 27 facilities leased to Genesis for gross sales proceeds of $235.9M. Of the remaining 19 facilities leased to Genesis that it plans to sell, five are currently under contract for sale with expected total gross sales proceeds of $40.4M, and 14 are under letter of intent with expected total gross sales proceeds of $75.8M.
  • Source: Press Release
  • Previously: Sabra Healthcare misses by $0.02, beats on revenue (Aug. 8)
  • Now read: It's Easy To Be Patient With This 8% Dividend


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.